<strong>Assessment of Endocrine-Disrupting Properties in Cosmetic Ingredients: Focus on UV Filters and Alternative Testing Methods</strong>

dc.contributor.authorMaddaleno Jiménez, Adriana Solange
dc.contributor.authorGuardia Escoté, Laia
dc.contributor.authorTeixidó Condomines, Elisabet
dc.contributor.authorVinardell Martínez-Hidalgo, Ma. Pilar
dc.contributor.authorMitjans Arnal, Montserrat
dc.date.accessioned2025-09-23T08:40:30Z
dc.date.available2025-09-23T08:40:30Z
dc.date.issued2025-08-16
dc.date.updated2025-09-23T08:40:30Z
dc.description.abstractEndocrine-disrupting chemicals are substances capable of interfering with hormonal systems, potentially leading to adverse developmental, reproductive, neurological, and immune effects in both humans and wildlife. Various experimental models are currently available to assess the endocrine-disrupting potential of substances. However, in the context of cosmetic ingredients, the ban on animal testing for safety and efficacy evaluations in Europe and other regions necessitates the use of in vitro or in silico approaches. Concerns have been raised regarding the possible endocrine-disrupting properties of certain cosmetic compounds, prompting the development of a priority substance list that includes several ultraviolet (UV) filters. This review provides a comprehensive overview of the main methodologies employed to evaluate endocrine-disrupting effects, with a particular focus on different endocrine organs. It also compiles and analyzes literature data related to commonly used UV filters such as benzophenones, avobenzone, homosalate, octocrylene, octinoxate, and 4-methylbenzylidene camphor. A major limitation identified is the lack of validated in vitro methods for assessing disruptions in specific endocrine organs, such as the thyroid and pancreas. This gap hinders accurate interpretation of experimental results and highlights the urgent need for further research to clarify the safety profiles of UV filters and other cosmetic ingredients.
dc.format.extent29 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec760099
dc.identifier.issn2079-9284
dc.identifier.urihttps://hdl.handle.net/2445/223352
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/cosmetics12040175
dc.relation.ispartofCosmetics, 2025, vol. 12, num.4, p. 175
dc.relation.urihttps://doi.org/10.3390/cosmetics12040175
dc.rightscc-by (c) Maddaleno, AS et al., 2025
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
dc.subject.classificationDisruptors endocrins
dc.subject.classificationExperimentació animal
dc.subject.classificationIndústria cosmètica
dc.subject.otherEndocrine disrupting chemicals
dc.subject.otherAnimal experimentation
dc.subject.otherCosmetics industry
dc.title<strong>Assessment of Endocrine-Disrupting Properties in Cosmetic Ingredients: Focus on UV Filters and Alternative Testing Methods</strong>
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
898598.pdf
Mida:
801.08 KB
Format:
Adobe Portable Document Format